Condition
Tuberculosis, Pleural
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06439810RecruitingPrimary
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT05397730CompletedPrimary
MTB cfDNA Levels in TBP
NCT06390969Completed
TBP Survey Among Respiratory Physicians
NCT06646237Not Yet RecruitingPrimary
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA in Hong Kong
NCT05935696Unknown
A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant Pleural Effusion
NCT02765087Not ApplicableUnknownPrimary
E-Nose: Diagnostic Tool for Pleural TB
Showing all 6 trials